ClinicalTrials.gov
ClinicalTrials.gov Menu

Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00168766
Recruitment Status : Completed
First Posted : September 15, 2005
Last Update Posted : September 16, 2013
Sponsor:
Information provided by:
Biogen